PetVivo Holdings, Inc. (PETV)
USD 0.61
(-3.48%)
USD 0.61
(-3.48%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 1.01 Million USD | 4816.77% |
| 2023 | 260.24 Thousand USD | -2.57% |
| 2022 | 267.12 Thousand USD | -18.36% |
| 2021 | 327.17 Thousand USD | -20.37% |
| 2020 | 410.88 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.15 Million USD | -9.62% |
| 2024 Q3 | 1.07 Million USD | -10.83% |
| 2024 Q4 | 1.01 Million USD | 6578.37% |
| 2024 FY | 1.01 Million USD | 290.76% |
| 2024 Q1 | 1.23 Million USD | -8.65% |
| 2023 Q1 | 250.4 Thousand USD | -6.26% |
| 2023 Q2 | 233.65 Thousand USD | -6.69% |
| 2023 Q4 | 260.24 Thousand USD | 18.53% |
| 2023 FY | 260.24 Thousand USD | -2.57% |
| 2023 Q3 | 219.56 Thousand USD | -6.03% |
| 2022 Q4 | 267.12 Thousand USD | 91.15% |
| 2022 FY | 267.12 Thousand USD | -18.36% |
| 2022 Q2 | 148.13 Thousand USD | -53.77% |
| 2022 Q1 | 320.43 Thousand USD | -2.06% |
| 2022 Q3 | 139.74 Thousand USD | -5.66% |
| 2021 Q2 | 381.61 Thousand USD | 170.94% |
| 2021 Q3 | 353.4 Thousand USD | -7.39% |
| 2021 FY | 327.17 Thousand USD | -20.37% |
| 2021 Q1 | 140.84 Thousand USD | -65.72% |
| 2021 Q4 | 327.17 Thousand USD | -7.42% |
| 2020 Q4 | 410.88 Thousand USD | 11.72% |
| 2020 Q1 | 356.54 Thousand USD | 0.0% |
| 2020 Q2 | 350.4 Thousand USD | -1.72% |
| 2020 Q3 | 367.77 Thousand USD | 4.96% |
| 2020 FY | 410.88 Thousand USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | -100.0% |
| 2015 Q3 | 68.56 Thousand USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 97.183% |
| BrainsWay Ltd. | 239 Thousand USD | -325.494% |
| Cerus Corporation | 59.79 Million USD | 98.299% |
| Envoy Medical, Inc. | 404 Thousand USD | -151.715% |
| electroCore, Inc. | 537 Thousand USD | -89.372% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -8374.417% |
| IceCure Medical Ltd | 376 Thousand USD | -170.46% |
| Inogen, Inc. | 18.27 Million USD | 94.434% |
| OrthoPediatrics Corp. | 13.45 Million USD | 92.444% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -411.02% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -179.588% |
| MaxCyte, Inc. | 17.96 Million USD | 94.341% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -1739.465% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 98.908% |
| PAVmed Inc | 2.96 Million USD | 65.644% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 83.635% |
| RxSight, Inc. | 1.21 Million USD | 16.026% |
| Sight Sciences, Inc. | 31.7 Million USD | 96.793% |
| SI-BONE, Inc. | 36.06 Million USD | 97.18% |
| TELA Bio, Inc. | 40.51 Million USD | 97.49% |
| Treace Medical Concepts, Inc. | 53 Million USD | 98.082% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | 33.141% |
| Acutus Medical, Inc. | 32.65 Million USD | 96.886% |
| Talis Biomedical Corporation | 16.78 Million USD | 93.942% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 74.86% |
| CVRx, Inc. | 30.38 Million USD | 96.653% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Bioventus Inc. | 366.99 Million USD | 99.723% |
| Venus Concept Inc. | 70.79 Million USD | 98.563% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | 18.253% |
| LivaNova PLC | 568.54 Million USD | 99.821% |
| 908 Devices Inc. | 3.92 Million USD | 74.117% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.801% |
| Nemaura Medical Inc. | 3.08 Million USD | 67.065% |
| NeuroPace, Inc. | 56.95 Million USD | 98.214% |
| LENSAR, Inc. | 1.75 Million USD | 41.89% |
| Apyx Medical Corporation | 33.18 Million USD | 96.936% |
| Cutera, Inc. | 418.69 Million USD | 99.757% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 93.24% |
| BioSig Technologies, Inc. | 103 Thousand USD | -887.311% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 96.22% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 89.779% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.932% |
| Axonics, Inc. | 25.84 Million USD | 96.065% |
| Outset Medical, Inc. | 134.59 Million USD | 99.244% |
| IRIDEX Corporation | 1.75 Million USD | 41.923% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 98.019% |
| IRadimed Corporation | 1.61 Million USD | 37.035% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -477.801% |
| INVO Bioscience, Inc. | 6.77 Million USD | 84.992% |
| Telesis Bio, Inc. | 5.26 Million USD | 80.7% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 82.97% |
| Varex Imaging Corporation | 464.2 Million USD | 99.781% |
| Quipt Home Medical Corp. | 60.82 Million USD | 98.328% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -72.947% |
| Pulmonx Corporation | 35.08 Million USD | 97.102% |
| Dynatronics Corporation | 3.25 Million USD | 68.791% |
| Modular Medical, Inc. | 817 Thousand USD | -24.471% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -573.464% |
| Semler Scientific, Inc. | 70 Thousand USD | -1352.757% |
| InMode Ltd. | 6.61 Million USD | 84.622% |
| Bruker Corporation | 1.14 Billion USD | 99.911% |
| Cytosorbents Corporation | 2.54 Million USD | 60.008% |
| DexCom, Inc. | 2.57 Billion USD | 99.96% |
| Align Technology, Inc. | 96.96 Million USD | 98.951% |
| Viveve Medical, Inc. | 5.12 Million USD | 80.154% |
| ZimVie Inc. | 508.79 Million USD | 99.8% |
| Movano Inc. | 15.00 USD | -6779433.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 94.389% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.745% |
| Profound Medical Corp. | 4.97 Million USD | 79.557% |
| Insulet Corporation | 1.36 Billion USD | 99.926% |
| enVVeno Medical Corporation | 1.06 Million USD | 4.424% |
| Surmodics, Inc. | 29.4 Million USD | 96.542% |
| iCAD, Inc. | 273 Thousand USD | -272.502% |
| Nuwellis, Inc. | 221 Thousand USD | -360.149% |
| Biotricity, Inc. | 10.85 Million USD | 90.632% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 97.09% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -56.511% |
| InspireMD, Inc. | 1.03 Million USD | 2.03% |
| PAVmed Inc. | 2.96 Million USD | 65.644% |
| BIOLASE, Inc. | 13.98 Million USD | 92.728% |
| Beyond Air, Inc. | 14.72 Million USD | 93.092% |
| FONAR Corporation | 37.92 Million USD | 97.319% |
| AxoGen, Inc. | 46.6 Million USD | 97.818% |
| Vivani Medical, Inc. | 19.31 Million USD | 94.734% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 97.721% |
| Inari Medical, Inc. | 30.35 Million USD | 96.65% |
| UFP Technologies, Inc. | 28 Million USD | 96.368% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -134.291% |
| Tenon Medical, Inc. | 428 Thousand USD | -137.6% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -1.49% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 52.749% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.951% |
| Sintx Technologies, Inc. | 3.68 Million USD | 72.418% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 97.268% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -72.947% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -70.626% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.886% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.799% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -67.534% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -999.562% |
| Hyperfine, Inc. | 64 Thousand USD | -1488.953% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.461% |
| Biomerica, Inc. | 459 Thousand USD | -121.553% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -126.244% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -435.263% |
| Silk Road Medical, Inc | 75.62 Million USD | 98.655% |